These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 9990463

  • 1. 2,6,9-trisubstituted purines: optimization towards highly potent and selective CDK1 inhibitors.
    Imbach P, Capraro HG, Furet P, Mett H, Meyer T, Zimmermann J.
    Bioorg Med Chem Lett; 1999 Jan 04; 9(1):91-6. PubMed ID: 9990463
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and biological activity of olomoucine II.
    Krystof V, Lenobel R, Havlícek L, Kuzma M, Strnad M.
    Bioorg Med Chem Lett; 2002 Nov 18; 12(22):3283-6. PubMed ID: 12392733
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of C2 alkynylated purines, a new family of potent inhibitors of cyclin-dependent kinases.
    Legraverend M, Ludwig O, Bisagni E, Leclerc S, Meijer L.
    Bioorg Med Chem Lett; 1998 Apr 07; 8(7):793-8. PubMed ID: 9871543
    [Abstract] [Full Text] [Related]

  • 4. 2,6,8,9-tetrasubstituted purines as new CDK1 inhibitors.
    Moravec J, Krystof V, Hanus J, Havlícek L, Moravcová D, Fuksová K, Kuzma M, Lenobel R, Otyepka M, Strnad M.
    Bioorg Med Chem Lett; 2003 Sep 15; 13(18):2993-6. PubMed ID: 12941319
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and in vitro evaluation of novel 2,6,9-trisubstituted purines acting as cyclin-dependent kinase inhibitors.
    Legraverend M, Ludwig O, Bisagni E, Leclerc S, Meijer L, Giocanti N, Sadri R, Favaudon V.
    Bioorg Med Chem; 1999 Jul 15; 7(7):1281-93. PubMed ID: 10465404
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles.
    Arris CE, Boyle FT, Calvert AH, Curtin NJ, Endicott JA, Garman EF, Gibson AE, Golding BT, Grant S, Griffin RJ, Jewsbury P, Johnson LN, Lawrie AM, Newell DR, Noble ME, Sausville EA, Schultz R, Yu W.
    J Med Chem; 2000 Jul 27; 43(15):2797-804. PubMed ID: 10956187
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
    Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP.
    Eur J Biochem; 1997 Jan 15; 243(1-2):527-36. PubMed ID: 9030781
    [Abstract] [Full Text] [Related]

  • 12. N2-substituted O6-cyclohexylmethylguanine derivatives: potent inhibitors of cyclin-dependent kinases 1 and 2.
    Hardcastle IR, Arris CE, Bentley J, Boyle FT, Chen Y, Curtin NJ, Endicott JA, Gibson AE, Golding BT, Griffin RJ, Jewsbury P, Menyerol J, Mesguiche V, Newell DR, Noble ME, Pratt DJ, Wang LZ, Whitfield HJ.
    J Med Chem; 2004 Jul 15; 47(15):3710-22. PubMed ID: 15239650
    [Abstract] [Full Text] [Related]

  • 13. Cyclin-dependent kinase inhibition by new C-2 alkynylated purine derivatives and molecular structure of a CDK2-inhibitor complex.
    Legraverend M, Tunnah P, Noble M, Ducrot P, Ludwig O, Grierson DS, Leost M, Meijer L, Endicott J.
    J Med Chem; 2000 Apr 06; 43(7):1282-92. PubMed ID: 10753466
    [Abstract] [Full Text] [Related]

  • 14. Suzuki-type Pd(0) coupling reactions in the synthesis of 2-arylpurines as Cdk inhibitors.
    Vandromme L, Piguel S, Lozach O, Meijer L, Legraverend M, Grierson DS.
    Bioorg Med Chem Lett; 2006 Jun 15; 16(12):3144-6. PubMed ID: 16616489
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synthesis and biological evaluation of guanidino analogues of roscovitine.
    Dolečková I, Cesnek M, Dračinský M, Brynda J, Voller J, Janeba Z, Kryštof V.
    Eur J Med Chem; 2013 Apr 15; 62():443-52. PubMed ID: 23399722
    [Abstract] [Full Text] [Related]

  • 17. 9-Benzyladenines: potent and selective cAMP phosphodiesterase inhibitors.
    Bourguignon JJ, Désaubry L, Raboisson P, Wermuth CG, Lugnier C.
    J Med Chem; 1997 Jun 06; 40(12):1768-70. PubMed ID: 9191951
    [No Abstract] [Full Text] [Related]

  • 18. Pyrazolo[4,3-d]pyrimidines as new generation of cyclin-dependent kinase inhibitors.
    Moravcová D, Krystof V, Havlícek L, Moravec J, Lenobel R, Strnad M.
    Bioorg Med Chem Lett; 2003 Sep 15; 13(18):2989-92. PubMed ID: 12941318
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis and biological properties of C-2, C-8, N-9 substituted 6-(3-chloroanilino)purine derivatives as cyclin-dependent kinase inhibitors. Part II.
    Oh CH, Kim HK, Lee SC, Oh C, Yang BS, Rhee HJ, Cho JH.
    Arch Pharm (Weinheim); 2001 Nov 15; 334(11):345-50. PubMed ID: 11822171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.